Admedus: Superior cardiovasculartissue- repair products

Based on its proprietary ADAPT tissue-engineering technology, Admedus is developing an expanding portfolio of next-generation 3D tissue products for cardiovascular repair. The products will expand its range of durable bioscaffolds, which have achieved 10 years without calcification or degradation.

Like Comment
Page of
Go to the profile of Admedus


Admedus is a medical technologies company delivering clinically superior solutions to help healthcare professionals to create life-changing outcomes for patients. dmedus Ltd started its life as Allied Healthcare Group Ltd when its two parent companies Allied Medical Ltd and bioMD Ltd (ASX: BOD) merged in 2011. In 2013, the Company changed its name from Allied Healthcare Group to Admedus Ltd as part of a global branding strategy, and acquired Verigen Australia Pty Ltd (now Admedus Biomanufacturing). The original merger of Allied Healthcare Group Ltd and bioMD Ltd created a unique healthcare company with assets in research & development, products in advanced clinical trials ready for commercialisation, and a successful sales, marketing and medical device distribution business. Since then, Admedus has continued to grow, expanding into new dynamic markets, investing in ground-breaking R&D and continuously refining our world-class manufacturing facility and processes.

No comments yet.